Your browser doesn't support javascript.
loading
Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.
Pal, Kuntal; Bandyopadhyay, Abhishek; Zhou, X Edward; Xu, Qingping; Marciano, David P; Brunzelle, Joseph S; Yerrum, Smitha; Griffin, Patrick R; Vande Woude, George; Melcher, Karsten; Xu, H Eric.
Afiliação
  • Pal K; Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
  • Bandyopadhyay A; Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
  • Zhou XE; Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
  • Xu Q; GMCA at Advanced Photon Source, Argonne National Laboratory, Lemont, IL 60439, USA.
  • Marciano DP; Department of Molecular Medicine, Translational Research Institute, The Scripps Research Institute, Scripps Florida, Jupiter, FL 33458, USA.
  • Brunzelle JS; Department of Molecular Pharmacology & Biological Chemistry, Life Sciences Collaborative Access Team, Synchrotron Research Center, Northwestern University, Argonne, IL 60439, USA.
  • Yerrum S; Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
  • Griffin PR; Department of Molecular Medicine, Translational Research Institute, The Scripps Research Institute, Scripps Florida, Jupiter, FL 33458, USA.
  • Vande Woude G; Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
  • Melcher K; Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, MI 49503, USA. Electronic address: karsten.melcher@vai.org.
  • Xu HE; Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, MI 49503, USA; VARI-SIMM Center for Structure and Function of Drug Targets and the CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Elect
Structure ; 25(6): 867-877.e3, 2017 06 06.
Article em En | MEDLINE | ID: mdl-28528776
ABSTRACT
The nuclear pore complex subunit TPR is found in at least five different oncogenic fusion kinases, including TPR-MET, yet how TPR fusions promote activation of kinases and their oncogenic activities remains poorly understood. Here we report the crystal structure of TPR(2-142), the MET fusion partner of oncogenic TPR-MET. TPR(2-142) contains a continuous 124-residue α helix that forms an antiparallel tetramer from two leucine zipper-containing parallel coiled coils. Remarkably, single mutations cause strikingly different conformations of the coiled coil, indicating its highly dynamic nature. We further show that fusion of TPR(2-142) to the MET intracellular domain strongly and selectively stabilizes the αG helix of the MET kinase domain, and mutations of only the TPR leucine zipper residues at the junction to MET, but not other leucine zipper residues, abolish kinase activation. Together, these results provide critical insight into the TPR structure and its ability to induce dimerization and activation of fusion kinases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Oncogênica tpr-met Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Oncogênica tpr-met Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article